ArticleCommunications medicine2026
Comprehensive validation of machine learning models predicting chemotherapy related electrolyte disorders in a multicenter study.
Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundElectrolyte abnormalities following chemotherapy are common and clinically significant complications in cancer patients and are often associated with treatment delays and adverse outcomes. This study aims to develop and validate machine learning models to predict eight electrolyte abnormalities in cancer patients receiving chemotherapy.
methodsWe retrospectively analyze medical records of cancer patients from two tertiary hospitals in Korea (n = 11,227). Four machine learning algorithms are used to predict eight electrolyte abnormalities occurring within 4 weeks of chemotherapy initiation. Model performance is evaluated using a comprehensive validation framework, including internal, external, and temporal validation, and model interpretability is assessed using Shapley additive explanations.
resultsHere we show that electrolyte abnormalities occur in 4451 patients (74.0%) in the internal cohort and 4414 patients (84.7%) in the external cohort, with in-hospital mortality rates of 35.9% and 32.8%, respectively. The best-performing models achieve an average area under the receiver operating characteristic curve of 0.798, with an average performance decline of 0.11 during external validation. Model interpretation identifies serum albumin, heart rate, and estimated glomerular filtration rate as the most important predictors across models. Risk stratification demonstrates that patients in the highest-risk quintile have 4.15-fold greater odds of developing electrolyte abnormalities, and a 2.02-fold higher risk of mortality compared with the moderate-risk.
conclusionsThese machine learning models provide an effective approach for predicting electrolyte abnormalities in cancer patients receiving chemotherapy and may support risk stratification and monitoring prioritization. Future studies are needed to validate these models in more diverse populations, incorporate additional biomarkers, and explore their integration into clinical decision-support systems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.